DK376187A - Peptider - Google Patents

Peptider

Info

Publication number: DK376187A
Authority: DK; Denmark
Prior art keywords: amino acid; insulin; charge; chain; neutral
Prior art date: 1986-07-21

Application number

DK376187A

Other languages

English (en)

Other versions

DK376187D0 (da

DK160880B (da

DK160880C (da

Inventor

Jan Markussen

Kjeld Norris

Liselotte Langkjaer

Original Assignee

Novo Industri As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-07-21

Filing date

1987-07-20

Publication date

1988-01-22

1986-07-21 Priority claimed from DK347086A external-priority patent/DK347086D0/da

1987-07-20 Application filed by Novo Industri As filed Critical Novo Industri As

1987-07-20 Priority to DK376187A priority Critical patent/DK160880C/da

1987-07-20 Publication of DK376187D0 publication Critical patent/DK376187D0/da

1988-01-22 Publication of DK376187A publication Critical patent/DK376187A/da

1991-04-29 Publication of DK160880B publication Critical patent/DK160880B/da

1991-10-14 Application granted granted Critical

1991-10-14 Publication of DK160880C publication Critical patent/DK160880C/da

Links

102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
150000001413 amino acids Chemical class 0.000 abstract 3
210000004899 c-terminal region Anatomy 0.000 abstract 2
230000007935 neutral effect Effects 0.000 abstract 2
101000976075 Homo sapiens Insulin Proteins 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003368 amide group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000002843 carboxylic acid group Chemical group 0.000 abstract 1
230000003111 delayed effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000004185 ester group Chemical group 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DK376187A 1986-07-21 1987-07-20 Insulinderivater samt injicerbare oploesninger indeholdende disse DK160880C (da)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
DK376187A DK160880C (da)	1986-07-21	1987-07-20	Insulinderivater samt injicerbare oploesninger indeholdende disse

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DK347086A DK347086D0 (da)	1986-07-21	1986-07-21	Novel peptides
DK347086		1986-07-21
DK376187A DK160880C (da)	1986-07-21	1987-07-20	Insulinderivater samt injicerbare oploesninger indeholdende disse
DK376187		1987-07-20

Publications (4)

Publication Number	Publication Date
DK376187D0 DK376187D0 (da)	1987-07-20
DK376187A true DK376187A (da)	1988-01-22
DK160880B DK160880B (da)	1991-04-29
DK160880C DK160880C (da)	1991-10-14

Family

ID=26067070

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK376187A DK160880C (da)	1986-07-21	1987-07-20	Insulinderivater samt injicerbare oploesninger indeholdende disse

Country Status (1)

Country	Link
DK (1)	DK160880C (da)

1987
- 1987-07-20 DK DK376187A patent/DK160880C/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK376187D0 (da)	1987-07-20
DK160880B (da)	1991-04-29
DK160880C (da)	1991-10-14

Similar Documents

Publication	Publication Date	Title
DK107086A (da)	1986-11-07	Peptider
DK347086D0 (da)	1986-07-21	Novel peptides
DE3262899D1 (en)	1985-05-09	Salts of valproic acid, their preparation and their use
AU517505B2 (en)	1981-08-06	Ornithine and arginine salts of branched chain keto acids
SE442013B (sv)	1985-11-25	Cykliska sulfonyloxiimider for anvendning vid framstellning av cykliska aminosyror
GB2181647B (en)	1989-10-11	Compositions based on lysine and arginine salts.
IT8619593A0 (it)	1986-02-28	Amminoacido ed imminoacido amminoalchilureido estere sostituito e composti estere.
KR840008279A (ko)	1984-12-14	아미노산 함유지방유제의 지방미립자화 방법
FI854178A7 (fi)	1986-04-28	1,2,4-triatsolo-karbamaatti ja sen happoadditiosuolat, näiden valmistusmenetelmät ja lääkeaineet.
DK376187A (da)	1988-01-22	Peptider
NO874623D0 (no)	1987-11-05	Syreholdig vaskemiddelblanding i pastaform samt fremgangsmaate for fremstilling derav.
AU666482B2 (en)	1996-02-15	Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
GB1555007A (en)	1979-11-07	Intermediates in the preparation of substituted cepham carboxylic acid derivatives and the preparation thereof
NO881661L (no)	1988-10-17	Humane rhinoviruspeptider.
FI792548A7 (fi)	1981-01-01	Fenyyliguanidiinisulfonihappoesterien monokarboksylaatteja, menetelmiä niiden valmistamiseksi ja niiden käytlääkeianeina.
FI864439L (fi)	1987-05-27	Karboksyyliryhmiä sisältävät polyamidit, menetelmä niiden valmistamiseksi ja niiden käyttö vesipitoisten pronssidispersioiden valmistamiseksi
JPS5639055A (en)	1981-04-14	S-polyprenylpeptides
FR2284117A1 (fr)	1976-04-02	Dosage radio-immunologique de la thyroxine totale dans le serum
ES2009280A6 (es)	1989-09-16	Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.
SE8701294L (sv)	1988-09-28	Hiv-peptid
JPS51143629A (en)	1976-12-10	2226dichlorophenylaminoethylguanidine its salts with acids and preparation thereof

Legal Events

Date	Code	Title	Description
2007-08-06	PUP	Patent expired